Stockreport

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting [Yahoo! Finance]

Genprex, Inc.  (GNPX) 
Last genprex, inc. earnings: 11/14 12:08 pm Check Earnings Report
PDF Research Collaborators Identify Biomarkers that May Predict Patient Response to Reqorsa ® Gene Therapy REQORSA is a Potential Treatment for ALK-EML4 Positive Transloc [Read more]